Sykes And Ray Equities Open An Account Button
SRE India Mobile Trading App Download Promotion
Sykes And Ray Equities India Start SIP Investment Visual
Sykes And Ray Equities India Start Trading Online Visual

Markets

Market Nav

News Details

03/07/2026 18:51

Bliss GVS Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, July 03, 2026

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors, at its meeting held today, i.e., Friday, July 03, 2026, through Video Conferencing (\VC\)/Other Audio-Visual Means (\OAVM\), with the deemed venue being the Registered Office of the Company inter-alia has considered and approved the:\r\n\r\n1. Appointment of Mr. Santosh Parab (DIN:01622988) as an Additional Director in the capacity of Non-Executive Non-Independent Director w.e.f. July 03, 2026. \r\n2. Appointment of Mr. Rahul Adakmol as Chief Executive Officer of the Company with effect from July 15, 2026.\r\n3. Mr. Narsimha Shibroor Kamath has stepped aside from the position of Chief Executive Officer with effect from close of business hours on July 14, 2026, while continuing to serve as the Managing Director of the Company. \r\n